IndraLab
Statements
sparser
"The criteria of benzoin from Chinese pharmacopoeia (ChP 2020), USA pharmacopoeia (USP43-NF38), European pharmacopoeia (EP10.0), Japanese pharmacopoeia (JP18) and Indian pharmacopoeia (IP2018) are summarized in xref , in which content determination, ethanol-insoluble matter, acid-insoluble ash, loss on drying, total ash and presence of dammar gum require detailed analysis [ xref , xref , xref , xref , xref ]."
sparser
"In addition, the limit of the number of micro-particles ≥10 and 25 μm in 100-mL filling-volume injections is consistent with those indicated in the pharmacopoeias of all countries, such as USP43–NF38, European Pharmacopoeia 10.0 and Chinese Pharmacopoeia 2020, with limits set as ≤12 and 2 particles/mL."
sparser
"The regulatory bodies have dealt with both the problem of species difference by proposing specific controls for veterinary pharmaceutical forms ( xref ; xref ) and the problem of dosage uniformity linked to the division of the tablets [Uniformity of Dosage Units <905>, USP43-NF38, 2020; Monograph 2.9.40, PhEur 9.1, 2017; Uniformity of Dosage Units 6.02, JP, 2018; ( xref )]."